Overview
Atrial Fibrillation
Cancer Associated Thrombosis
The Promise of Factor XI
Abelacimab: A Novel Anticoagulant
Clinical Development Program
Our Mission
Our Team
Milestones & Achievements
Patient Advocacy
Healthcare Professionals
Biotech Nation
https://www.biotechnation.com/episodes/combatting-blood-clots-dr-daniel-bloomfield-chief-medical-officer-anthos-therapeutics
